Abstract
An exceptional in depth study of BRCA1 and 2 mutations and their outcomes in over one thousand Ashkenazi Jewish patients. Lifetime risk of developing disease among gene carriers was 82% and seems to be increasing with time. Significantly, many cases came from families with little or no family history (by chance or because the gene came through the father) and the lifetime risk was as great in these women.